Newsletter

News

Good news from biocrates

The latest in metabolomics

In our news section we are dedicted to keeping you informed and enganged with the dynamic world of metabolomics. We deliver information on metabolomics events and webinars, interesting and surprising facts about metabolites, new products, our blog and selected peer-reviewed publications.

MxP® Quant 1000 assay

Recordings of the launch event are available

The MxP® Quant 1000 assay has officially launched, and the webinar recordings are now available! Explore this advanced assay, enabling the screening of over 1,200 analytes from just 40 microliters of sample. Alice Limonciel and Markus Langsdorf explain how it works and how standardized assays and AI-powered analysis are advancing health and disease research.

Tech note MxP® Quant 1000 kit

Coverage and precision across biological matrices

In this technical note the MxP® Quant 1000 kit is evaluated across plasma, urine, and feces, with high precision, robust detection, and matrix-specific methods. The kit offers unparalleled flexibility and coverage for quantitative targeted metabolomics. Combined with MetaboINDICATOR, the MxP® Quant 1000 delivers up to 1,881 potential biomarkers empowering multiomics research.

Metabolite of the month

Propionic acid

In this section, our scientists focus on a specific metabolite each month, discussing its function and implications for neurological and cardiovascular health.This month’s article takes a closer look at propionic acid, a short-chain fatty acid with big impact.

Transform medicine with metabolomics

Precision medicine – part 3 of 5

This month’s 5P medicine article explores how metabolomics is driving real-world applications of precision medicine, especially in predictive diagnostics, treatment optimization, and personalized nutrition. Learn why sex-based data stratification is essential, how metabolic profiles reveal hidden disease subtypes, and why the future of medicine is personal.

🎧 The Metabolomist podcast 🎧

Season IV

The Metabolomist is back!
Season IV explores one big theme – 5P medicine with metabolomics. In the first episode, our host Alice Limonciel, Chief Scientific Officer at biocrates, speaks with Cristina Legido-Quigley from King’s College London and Steno Diabetes Center Copenhagen about neurometabolism, disease coping, and personalized medicine in diabetes and metabolic diseases.

Strategic collaboration with Platomics

A game-changer for the adoption of metabolomics

We are excited to announce a collaboration with Platomics to streamline metabolomics adoption in laboratories. Integrating biocrates’ kits into the PlatoX® platform simplifies quality assurance, ensuring reproducible results with less effort. Laboratories can seamlessly incorporate regulatory guidance into workflows, from sample preparation to data analysis, accelerating standardized and compliant research.

Partnership to make metabolomics accessible

biovis and biocrates launch personalized health test

With Prevent360, biovis and biocrates enable individuals to monitor 75 key health parameters, backed by personalized recommendations for nutrition, exercise, and overall wellness. This breakthrough reflects our shared passion for innovation and our vision of giving people the knowledge they need to proactively manage their health.

Transform medicine with metabolomics

Predictive medicine – part 2 of 5

In this five-part blog series, we explore the role of metabolomics in 5P medicine. This second installment highlights how screening samples with broad metabolomics panels and leveraging data with knowledge-driven tools leads to the translation of metabolomics insights into innovative strategies for predictive medicine.

Transform medicine with metabolomics

Preventive medicine – part 1 of 5

Metabolomics is poised to revolutionize medicine through 5P approach, which encompasses preventive, predictive, precise, participatory and population-based healthcare strategies. This first article in a five-part series focuses on prevention, illustrating how metabolomics aids in detecting early disease risks and facilitates personalized lifestyle and dietary interventions.

Nutrition and consumer well-being

How metabolomics drives personalized medicine

Metabolomics improves precision nutrition by uncovering real-time connections between diet and health. Metabolic biomarkers enable objective, personalized advice on diet and other lifestyle factors, unlike error-prone food journals. This article explores how metabolic profiling enhances the accuracy of nutrition and health assessments. It also discusses integration of metabolomics into consumer tests using at-home sampling to support health monitoring.

biocrates YouTube channel

Dedicated to the world of metabolomics

Explore our YouTube channel for a wealth of resources, including technical tutorials, insightful webinars, and our podcast “The Metabolomist”, all dedicated to the world of metabolomics. Whether you’re a beginner or an experienced researcher, our videos and podcasts offer in-depth discussions, practical guidance, and the latest updates in multiomics. Subscribe now to stay informed!

 

Subscribe to our newsletter

Is this for you?

We compile information on metabolomics on a monthly basis. If you are interested in getting this information first hand via e-mail, please provide your info in the enrolment form.

In case you do not like our format or the content you get delivered, you can unsubscribe at any time.

What happens next?

After entering your name, email address and the captcha you will receive a system-generated email asking you to confirm your subscription. Only after you hit the confirm button from this email you are ready to receive our communications. In case you do not receive the confirmation email, take a look in your spam folder. Sometimes automatically generated emails get sorted wrongly. In case you did not receive the mail, please contact us directly and we sort it out.


Please complete this form to receive email updates from biocrates.
Your email *
First name 
Last name 
*
*Required Fields
I agree to the Privacy Policy and our Terms and Conditions. 
OSZAR »